Literature DB >> 25744293

A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort.

Laureen Dartois1, Émilien Gauthier, Julia Heitzmann, Laura Baglietto, Stefan Michiels, Sylvie Mesrine, Marie-Christine Boutron-Ruault, Suzette Delaloge, Stéphane Ragusa, Françoise Clavel-Chapelon, Guy Fagherazzi.   

Abstract

Breast cancer remains a global health concern with a lack of high discriminating prediction models. The k-nearest-neighbor algorithm (kNN) estimates individual risks using an intuitive tool. This study compares the performances of this approach with the Cox and the Gail models for the 5-year breast cancer risk prediction. The study included 64,995 women from the French E3N prospective cohort. The sample was divided into a learning (N = 51,821) series to learn the models using fivefold cross-validation and a validation (N = 13,174) series to evaluate them. The area under the receiver operating characteristic curve (AUC) and the expected over observed number of cases (E/O) ratio were estimated. In the two series, 393 and 78 premenopausal and 537 and 98 postmenopausal breast cancers were diagnosed. The discrimination values of the best combinations of predictors obtained from cross-validation ranged from 0.59 to 0.60. In the validation series, the AUC values in premenopausal and postmenopausal women were 0.583 [0.520; 0.646] and 0.621 [0.563; 0.679] using the kNN and 0.565 [0.500; 0.631] and 0.617 [0.561; 0.673] using the Cox model. The E/O ratios were 1.26 and 1.28 in premenopausal women and 1.44 and 1.40 in postmenopausal women. The applied Gail model provided AUC values of 0.614 [0.554; 0.675] and 0.549 [0.495; 0.604] and E/O ratios of 0.78 and 1.12. This study shows that the prediction performances differed according to menopausal status when using parametric statistical tools. The k-nearest-neighbor approach performed well, and discrimination was improved in postmenopausal women compared with the Gail model.

Entities:  

Mesh:

Year:  2015        PMID: 25744293     DOI: 10.1007/s10549-015-3321-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  Discrimination of Breast Cancer with Microcalcifications on Mammography by Deep Learning.

Authors:  Jinhua Wang; Xi Yang; Hongmin Cai; Wanchang Tan; Cangzheng Jin; Li Li
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

2.  Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.

Authors:  Xin Wang; Yubei Huang; Lian Li; Hongji Dai; Fengju Song; Kexin Chen
Journal:  Breast Cancer Res       Date:  2018-03-13       Impact factor: 6.466

3.  Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.

Authors:  Tess V Clendenen; Wenzhen Ge; Karen L Koenig; Yelena Afanasyeva; Claudia Agnoli; Louise A Brinton; Farbod Darvishian; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Anne Zeleniuch-Jacquotte; Mengling Liu
Journal:  Breast Cancer Res       Date:  2019-03-19       Impact factor: 6.466

4.  Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic.

Authors:  Mahasti Saghatchian; Marc Abehsera; Amina Yamgnane; Caroline Geyl; Emilien Gauthier; Valérie Hélin; Matéo Bazire; Laure Villoing-Gaudé; Cécile Reyes; David Gentien; Lisa Golmard; Dominique Stoppa-Lyonnet
Journal:  Breast Cancer Res Treat       Date:  2022-01-07       Impact factor: 4.624

Review 5.  Assessment of the risk of developing breast cancer using the Gail model in Asian females: A systematic review.

Authors:  Solikhah Solikhah; Sitti Nurdjannah
Journal:  Heliyon       Date:  2020-04-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.